Alpine Associates Management’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Alpine Associates Management’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-20,932	Closed	-$832K	–	80
2016 Q3	$832K	Buy	+20,932	New	+$234K	0.03%	54

Alpine Associates Management's TBRA Position: Q4 2016 in Review

Alpine Associates Management sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 20,932 shares — an estimated $832K sold.

Alpine Associates Management first reported a position in TBRA in Q3 2016 and held it in 1 quarter. The position peaked at $832K in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

Alpine Associates Management reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Alpine Associates Management sold 20,932 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $832K.
Alpine Associates Management first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2016 and held it in 1 quarter.
Alpine Associates Management's Tobira Therapeutics, Inc. Common Stock position peaked at $832K in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Alpine Associates Management's 13F filing for Q4 2016, filed 13 Feb 2017.